Close Monitoring of CRP and Fecal Calprotectin is Able to Predict Clinical Relapse in Patients With Crohn’s Disease in Remission After Infliximab Withdrawal. A Sub-Analysis of the Stori Study.

N de Suray, J Salleron, G Vernier-Massouille, JC Grimaud, Y Bouhnik, D Laharie, JL Dupas, H Pillant-Le Moult, L Picon, M Veyrac, M Flamant, G Savoye, R Jian, M De Vos, E Piver, JF Colombel, E Louis and the GETAID

https://www.getaid.org/images/publications/DDW_2012_864.pdf